Reagents and consumables for HPV/CT/NG testing

Ended Awarded Last action

Contract number
36C25226N0075
Awardee
Awarding agency
Obligated
$399,950

Award facts

Contract value 100% obligated
$399,950.22 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$50
Original award $400,000

About this award

VISN 12 issued a BPA call to Roche Diagnostics Corporation on October 1, 2025, for reagents and consumables supporting HPV, CT, and NG testing, with a ceiling value of $399,950.22 under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule.

Performance occurs in Castleton, Indiana. The call runs through March 31, 2026. Roche will supply testing reagents and associated consumables for human papillomavirus, chlamydia trachomatis, and neisseria gonorrhoeae molecular diagnostic assays. The contract is firm fixed price with no set-aside designation.

Quick answers

Who was awarded contract 36C25226N0075?

36C25226N0075 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on October 1, 2025.

How much is contract 36C25226N0075 worth?

The government has obligated $399,950 on 36C25226N0075.

Is contract 36C25226N0075 an order under another contract?

Yes. 36C25226N0075 is a BPA call under V797D70105-36C25220A0031, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C25226N0075 competed?

The extent of competition for 36C25226N0075 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award